BioSpace News Archive

Bayer’s KERENDIA® (finerenone) was recognized by the American Diabetes Association (ADA) Standards of Medical Care in Diabetes—2022 with a new grade A recommendation* for improving cardiovascular (CV) outcomes and reducing the risk of chronic kidney disease (CKD) progression in patients with CKD associated with type 2 diabetes (T2D).

Adial Pharmaceuticals, Inc., issued the following letter to its shareholders from the Company’s CEO, William Stilley.

Saama Technologies, LLC. (“Saama”) today announced that Vivek Sharma has joined the company as Chief Executive Officer (CEO).

According to Latest Study, the global micro-pumps market was surpassed at USD 1.7 billion in 2021 and is expected to hit around USD 6.9 billion by 2030, growing at a CAGR of 16.84% from 2022 to 2030.

According to Vision Research Reports, the global medical imaging market was valued at USD 28.1 billion in 2021 and it is predicted to surpass around USD 47.6 billion by 2030 with a CAGR of 6.03% from 2022 to 2030.

The global Infantile Spasms Therapeutics market size is projected to reach US$ 182.4 million by 2028, from US$ 142 million in 2021, at a CAGR of 3.6% during 2022-2030.

The global G-Protein Coupled Receptor (GPCR) Targeting market size is estimated to be worth US$ 88 million in 2021 and is forecast to a readjusted size of US$ 105.5 million by 2028 with a CAGR of 2.6% during the forecast period 2022-2030.

Wilmington, Delaware, United States: Continuous developments in the biopharmaceutical field are projected to create profitable business opportunities in the global sterility testing market in the forthcoming years.

Fact.MR – A Market Research and Competitive Intelligence Provider: The Ophthalmic Ultrasound Devices Market revenues were estimated at US$ 432.2 Mn in 2021 and is anticipated to grow at a CAGR of 9.0% from 2022-2032, according to a recently published Fact.MR report.

On June 14, 2021, RoyalPhilips’ subsidiary Philips Respironics, initiated a voluntary recall notification/field safety notice* to address potential health risks related to the polyester-based polyurethane sound abatement foam in specific CPAP, BiPAP and mechanical ventilator devices.